{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T12:45:17Z","timestamp":1782391517754,"version":"3.54.5"},"reference-count":42,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2020,7,2]],"date-time":"2020-07-02T00:00:00Z","timestamp":1593648000000},"content-version":"unspecified","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003061","name":"Erasmus Medisch Centrum","doi-asserted-by":"publisher","award":["Fellowship"],"award-info":[{"award-number":["Fellowship"]}],"id":[{"id":"10.13039\/501100003061","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Diab Res Care"],"accepted":{"date-parts":[[2020,5,18]]},"published-print":{"date-parts":[[2020,7]]},"abstract":"<jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>Recent studies revealed <jats:italic>N<\/jats:italic>-glycosylation signatures of type 2 diabetes, inflammation and cardiovascular risk factors. Most people with diabetes use medication to reduce cardiovascular risk. The association of these medications with the plasma <jats:italic>N<\/jats:italic>-glycome is largely unknown. We investigated the associations of metformin, statin, ACE inhibitor\/angiotensin II receptor blocker (ARB), sulfonylurea (SU) derivatives and insulin use with the total plasma <jats:italic>N<\/jats:italic>-glycome in type 2 diabetes.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Research design and methods<\/jats:title>\n                  <jats:p>After enzymatic release from glycoproteins, <jats:italic>N<\/jats:italic>-glycans were measured by matrix-assisted laser desorption\/ionization mass spectrometry in the DiaGene (n=1815) and Hoorn Diabetes Care System (n=1518) cohorts. Multiple linear regression was used to investigate associations with medication, adjusted for clinical characteristics. Results were meta-analyzed and corrected for multiple comparisons.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Metformin and statins were associated with decreased fucosylation and increased galactosylation and sialylation in glycans unrelated to immunoglobulin G. Bisection was increased within diantennary fucosylated non-sialylated glycans, but decreased within diantennary fucosylated sialylated glycans. Only few glycans were associated with ACE inhibitor\/ARBs, while none associated with insulin and SU derivative use.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>We conclude that metformin and statins associate with a total plasma <jats:italic>N<\/jats:italic>-glycome signature in type 2 diabetes. Further studies are needed to determine the causality of these relations, and future <jats:italic>N<\/jats:italic>-glycomic research should consider medication a potential confounder.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjdrc-2020-001230","type":"journal-article","created":{"date-parts":[[2020,7,3]],"date-time":"2020-07-03T02:05:38Z","timestamp":1593741938000},"page":"e001230","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":16,"title":["Metformin and statin use associate with plasma protein <i>N<\/i>-glycosylation in people with type 2 diabetes"],"prefix":"10.1136","volume":"8","author":[{"given":"Sunny S","family":"Singh","sequence":"first","affiliation":[{"name":"Internal Medicine, Erasmus MC, Rotterdam, The Netherlands"},{"name":"Internal Medicine, Maxima Medical Centre, Eindhoven, Noord-Brabant, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annemieke","family":"Naber","sequence":"additional","affiliation":[{"name":"Internal Medicine, Erasmus MC, Rotterdam, The Netherlands"},{"name":"Internal Medicine, Maxima Medical Centre, Eindhoven, Noord-Brabant, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9888-7409","authenticated-orcid":false,"given":"Viktoria","family":"Dotz","sequence":"additional","affiliation":[{"name":"Center for Proteomics and Metabolomics, LUMC, Leiden, Zuid-Holland, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Schoep","sequence":"additional","affiliation":[{"name":"Cell and Chemical Biology, LUMC, Leiden, Zuid-Holland, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elham","family":"Memarian","sequence":"additional","affiliation":[{"name":"Center for Proteomics and Metabolomics, LUMC, Leiden, Zuid-Holland, The Netherlands"},{"name":"Research Laboratory, Genos Glycoscience, Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0961-9152","authenticated-orcid":false,"given":"Roderick C","family":"Slieker","sequence":"additional","affiliation":[{"name":"Cell and Chemical Biology, LUMC, Leiden, Zuid-Holland, The Netherlands"},{"name":"Department of Epidemiology and Biostatistics, VUMC, Amsterdam, Noord-Holland, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra J M","family":"Elders","sequence":"additional","affiliation":[{"name":"Department of General Practice and Elderly Care, Amsterdam Public Health Research Institute, Amsterdam UMC\u2014Locatie VUMC, Amsterdam, Noord-Holland, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerda","family":"Vreeker","sequence":"additional","affiliation":[{"name":"Center for Proteomics and Metabolomics, LUMC, Leiden, Zuid-Holland, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Nicolardi","sequence":"additional","affiliation":[{"name":"Center for Proteomics and Metabolomics, LUMC, Leiden, Zuid-Holland, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manfred","family":"Wuhrer","sequence":"additional","affiliation":[{"name":"Center for Proteomics and Metabolomics, LUMC, Leiden, Zuid-Holland, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric J G","family":"Sijbrands","sequence":"additional","affiliation":[{"name":"Internal Medicine, Erasmus MC, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aloysius G","family":"Lieverse","sequence":"additional","affiliation":[{"name":"Internal Medicine, Maxima Medical Centre, Eindhoven, Noord-Brabant, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4401-2938","authenticated-orcid":false,"given":"Leen M","family":"'t Hart","sequence":"additional","affiliation":[{"name":"Cell and Chemical Biology, LUMC, Leiden, Zuid-Holland, The Netherlands"},{"name":"Department of Epidemiology and Biostatistics, VUMC, Amsterdam, Noord-Holland, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2957-5436","authenticated-orcid":false,"given":"Mandy","family":"van Hoek","sequence":"additional","affiliation":[{"name":"Internal Medicine, Erasmus MC, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2020,7,2]]},"reference":[{"key":"2025073112194697000_8.1.e001230.1","first-page":"281","article-title":"The current total economic burden of diabetes mellitus in the Netherlands","volume":"75","author":"Peters","year":"2017","journal-title":"Neth J Med"},{"key":"2025073112194697000_8.1.e001230.2","unstructured":"David Walt KFA-K , Bendiak B , Bertozzi CR , et al . Transforming glycoscience: a roadmap for the future, 2012."},{"key":"2025073112194697000_8.1.e001230.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2006.08.019"},{"key":"2025073112194697000_8.1.e001230.4","doi-asserted-by":"publisher","DOI":"10.1093\/glycob\/cww086"},{"key":"2025073112194697000_8.1.e001230.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.sbi.2011.08.005"},{"key":"2025073112194697000_8.1.e001230.6","doi-asserted-by":"crossref","DOI":"10.1186\/gb-2001-2-5-reviews0004","article-title":"Characterizing glycosylation pathways","volume":"2","author":"Yarema","year":"2001","journal-title":"Genome Biol"},{"key":"2025073112194697000_8.1.e001230.7","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1016\/j.bbagen.2017.06.020","article-title":"Igg glycan patterns are associated with type 2 diabetes in independent European populations","volume":"1861","author":"Lemmers","year":"2017","journal-title":"Biochim Biophys Acta Gen Subj"},{"key":"2025073112194697000_8.1.e001230.8","doi-asserted-by":"publisher","DOI":"10.1002\/1873-3468.13495"},{"key":"2025073112194697000_8.1.e001230.9","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.1002\/1873-3468.13598","article-title":"N-Glycome signatures in human plasma: associations with physiology and major diseases","volume":"593","author":"Dotz","year":"2019","journal-title":"FEBS Lett"},{"key":"2025073112194697000_8.1.e001230.10","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.cellimm.2018.07.009","article-title":"Immunoglobulin G glycosylation in aging and diseases","volume":"333","author":"Gudelj","year":"2018","journal-title":"Cell Immunol"},{"key":"2025073112194697000_8.1.e001230.11","doi-asserted-by":"publisher","DOI":"10.2165\/00129784-200707030-00007"},{"key":"2025073112194697000_8.1.e001230.12","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.jdiacomp.2015.12.017","article-title":"Diabetes medications: impact on inflammation and wound healing","volume":"30","author":"Salazar","year":"2016","journal-title":"J Diabetes Complications"},{"key":"2025073112194697000_8.1.e001230.13","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.bbagen.2017.02.029","article-title":"Effects of statins on the immunoglobulin G glycome","volume":"1861","author":"Keser","year":"2017","journal-title":"Biochim Biophys Acta Gen Subj"},{"key":"2025073112194697000_8.1.e001230.14","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s13098-017-0245-x","article-title":"Introduction of the DiaGene study: clinical characteristics, pathophysiology and determinants of vascular complications of type 2 diabetes","volume":"9","author":"van Herpt","year":"2017","journal-title":"Diabetol Metab Syndr"},{"key":"2025073112194697000_8.1.e001230.15","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-015599"},{"key":"2025073112194697000_8.1.e001230.16","first-page":"S81","article-title":"Diagnosis and classification of diabetes mellitus","volume":"37 Suppl 1","year":"2014","journal-title":"Diabetes Care"},{"key":"2025073112194697000_8.1.e001230.17","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S"},{"key":"2025073112194697000_8.1.e001230.18","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-145-4-200608150-00004"},{"key":"2025073112194697000_8.1.e001230.19","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1016\/j.bbagen.2018.08.005","article-title":"Plasma protein N-glycan signatures of type 2 diabetes","volume":"1862","author":"Dotz","year":"2018","journal-title":"Biochim Biophys Acta Gen Subj"},{"key":"2025073112194697000_8.1.e001230.20","doi-asserted-by":"publisher","DOI":"10.1021\/ac500335t"},{"key":"2025073112194697000_8.1.e001230.21","doi-asserted-by":"crossref","first-page":"4080","DOI":"10.1021\/acs.jproteome.5b00538","article-title":"Automatio\n                  \n                     n\n                  \n                of high-throughput mass spectrometry-based plasma \n                  \n                     N\n                  \n               -glycome analysis with linkage-specific sialic acid esterificatio\n                  \n                     n","volume":"14","author":"Bladergroen","year":"2015","journal-title":"J Proteome Res"},{"key":"2025073112194697000_8.1.e001230.22","doi-asserted-by":"crossref","first-page":"11955","DOI":"10.1021\/acs.analchem.8b02391","article-title":"Automated plasma glycomics with linkage-specific sialic acid esterification and ultrahigh resolution MS","volume":"90","author":"Vreeker","year":"2018","journal-title":"Anal Chem"},{"key":"2025073112194697000_8.1.e001230.23","unstructured":"R Core Team . R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing, 2019. https:\/\/www.R-project.org\/"},{"key":"2025073112194697000_8.1.e001230.24","unstructured":"Schwarzer G . Package meta, 2019. Available: https:\/\/cran.r-project.org\/web\/packages\/meta\/meta.pdf"},{"key":"2025073112194697000_8.1.e001230.25","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J R Stat Soc Series B"},{"key":"2025073112194697000_8.1.e001230.26","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-013-2991-0"},{"key":"2025073112194697000_8.1.e001230.27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0119983"},{"key":"2025073112194697000_8.1.e001230.28","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1007\/s00125-017-4426-9","article-title":"Increased plasma N-glycome complexity is associated with higher risk of type 2 diabetes","volume":"60","author":"Keser","year":"2017","journal-title":"Diabetologia"},{"key":"2025073112194697000_8.1.e001230.29","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.270.13.7543"},{"key":"2025073112194697000_8.1.e001230.30","article-title":"Regulation of B cell functions by the sialic acid-binding receptors siglec-G and CD22","volume":"2","author":"Jellusova","year":"2011","journal-title":"Front Immunol"},{"key":"2025073112194697000_8.1.e001230.31","unstructured":"Tsubata T . Siglec-2 is a key molecule for immune response, 2008."},{"key":"2025073112194697000_8.1.e001230.32","doi-asserted-by":"crossref","DOI":"10.1007\/s00125-017-4515-9","article-title":"Correction to: increased plasma N-glycome complexity is associated with higher risk of type 2 diabetes","volume":"61","author":"Keser","year":"2018","journal-title":"Diabetologia"},{"key":"2025073112194697000_8.1.e001230.33","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.cca.2016.06.012","article-title":"Inflammatory glycoproteins in cardiometabolic disorders, autoimmune diseases and cancer","volume":"459","author":"Connelly","year":"2016","journal-title":"Clin Chim Acta"},{"key":"2025073112194697000_8.1.e001230.34","doi-asserted-by":"publisher","DOI":"10.1007\/s10719-015-9626-2"},{"key":"2025073112194697000_8.1.e001230.35","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2008.04.052"},{"key":"2025073112194697000_8.1.e001230.36","doi-asserted-by":"publisher","DOI":"10.1038\/srep31234"},{"key":"2025073112194697000_8.1.e001230.37","doi-asserted-by":"publisher","DOI":"10.1074\/mcp.M116.065250"},{"key":"2025073112194697000_8.1.e001230.38","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00877"},{"key":"2025073112194697000_8.1.e001230.39","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-017-0239-5","article-title":"Downregulation of \u03b21,4-galactosyltransferase 5 improves insulin resistance by promoting adipocyte commitment and reducing inflammation","volume":"9","author":"Li","year":"2018","journal-title":"Cell Death Dis"},{"key":"2025073112194697000_8.1.e001230.40","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s13318-017-0427-9","article-title":"Effects of metformin and furosemide on rosuvastatin pharmacokinetics in healthy volunteers: implications for their use as probe drugs in a transporter cocktail","volume":"43","author":"Stopfer","year":"2018","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"2025073112194697000_8.1.e001230.41","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2009.11.038"},{"key":"2025073112194697000_8.1.e001230.42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0209515"}],"container-title":["BMJ Open Diabetes Research &amp; Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjdrc-2020-001230","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T19:19:55Z","timestamp":1753989595000},"score":1,"resource":{"primary":{"URL":"https:\/\/drc.bmj.com\/lookup\/doi\/10.1136\/bmjdrc-2020-001230"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,7,2]]},"published-print":{"date-parts":[[2020,7]]}},"alternative-id":["10.1136\/bmjdrc-2020-001230"],"URL":"https:\/\/doi.org\/10.1136\/bmjdrc-2020-001230","relation":{},"ISSN":["2052-4897"],"issn-type":[{"value":"2052-4897","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7]]}}}